<?xml version="1.0" encoding="UTF-8"?>
<p>Elansary et al. published data regarding the anticancer activity of 
 <italic>Origanum vulgare</italic> L. (northern Egypt) essential oil (50, 100, 200, 300, and 400 μg/mL) against several cancer cell lines using MTT assay: breast adenocarcinoma (MCF-7), cervical adenocarcinoma (HeLa), T-cell lymphoblast (Jurkat), colon adenocarcinoma (HT-29), and urinary bladder carcinoma (T24) and human cell line (HEK-293). Compared to positive controls (vinblastine sulfate and taxol) OEO presented significant antitumoral activities against MCF-7 (IC
 <sub>50</sub> = 8.11 µg/mL, taxol-IC
 <sub>50</sub> = 0.08 µg/mL), HeLa(IC
 <sub>50</sub> = 13.41 µg/mL, vinblastine-IC
 <sub>50</sub> = 2.5 µg/mL), Jurkat(IC
 <sub>50</sub> = 27,05 µg/mL, vinblastine-IC
 <sub>50</sub> = 0.1 µg/mL), HT-29(IC
 <sub>50</sub> = 12.18 µg/mL, vinblastine-IC
 <sub>50</sub> = 12.18 µg/mL), T24(IC
 <sub>50</sub> = 105.5 µg/mL, vinblastine-IC
 <sub>50</sub> = 63.31 µg/mL) cancer cell lines [
 <xref rid="B38-ijms-21-09653" ref-type="bibr">38</xref>].
</p>
